申请人:Eisai Co., Ltd.
公开号:US20020086999A1
公开(公告)日:2002-07-04
A novel 1,4-substituted cyclic amine derivative represented by the following formula:
1
wherein A, B, C, D, T, Y, and Z represent each methine or nitrogen; R
1
, R
2
, R
3
, R
4
, and R
5
represent each a substituent; n represents 0 or an integer of 1 to 3; m represents 0 or an integer of 1 to 6; and p represents an integer of 1 to 3; and pharmacologically acceptable salts thereof. The compound has a serotonin antagonism and is clinically useful as medicament, in particular, for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia.
由下式表示的新型 1,4-取代环胺衍生物:
1
其中 A、B、C、D、T、Y 和 Z 分别代表甲烷或氮; R
1
, R
2
, R
3
, R
4
和 R
5
分别代表一个取代基;n 代表 0 或 1 至 3 的整数;m 代表 0 或 1 至 6 的整数;p 代表 1 至 3 的整数;及其药理上可接受的盐类。该化合物具有血清素拮抗作用,在临床上可用作药物,特别是用于治疗、改善和预防痉挛性瘫痪或用于改善肌张力的中枢性肌肉松弛剂。